|
English
|
正體中文
|
简体中文
|
2822808
|
|
???header.visitor??? :
29948935
???header.onlineuser??? :
994
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"mok t"???jsp.browse.items-by-author.description???
Showing items 51-52 of 52 (3 Page(s) Totally)
<< < 1 2 3
View [10|25|50] records per page
| 臺大學術典藏 |
2014 |
Treatment of advanced non-small-cell lung cancer with epidermal growth factor receptor (EGFR) mutation or ALK gene rearrangement: Results of an International expert panel meeting of the Italian association of thoracic oncology
|
Gridelli C;De Marinis F;Cappuzzo F;Di Maio M;Hirsch F.R;Mok T;Morgillo F;Rosell R;Spigel D.R;Chih-Hsin Yang;Ciardiello F.; Gridelli C; De Marinis F; Cappuzzo F; Di Maio M; Hirsch F.R; Mok T; Morgillo F; Rosell R; Spigel D.R; CHIH-HSIN YANG; Ciardiello F. |
| 國立臺灣大學 |
2013 |
Epidermal growth factor receptor (EGFR)-mediated adverse events (AEs) in patients (pts) with EGFR mutation positive (EGFR M plus ) non-small cell lung cancer treated with afatinib
|
Yang, J. Chih-Hsin; Sequist, L.; O'Byrne, K.; Schuler, M.; Mok, T.; Geater, S.; Massey, D.; O'Brien, D.; Zazulina, V.; Wu, Y. L.; 楊志新 |
Showing items 51-52 of 52 (3 Page(s) Totally)
<< < 1 2 3
View [10|25|50] records per page
|
